KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
26.66
+0.01 (0.04%)
At close: May 4, 2026, 4:00 PM EDT
26.74
+0.08 (0.30%)
Pre-market: May 5, 2026, 5:06 AM EDT
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $1.37 billion as of May 4, 2026. Its market cap has increased by 128.90% in one year.
Market Cap
1.37B
Enterprise Value
1.35B
1-Year Change
128.90%
Ranking
Category
Stock Price
$26.66
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $1.37B, an increase of 956.14%. That is a compound annual growth rate of 23.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 1.37B | 67.29% |
| Dec 31, 2025 | 816.30M | 95.01% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
| Apr 9, 2015 | 129.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.45B |
| Wave Life Sciences | 1.44B |
| MBX Biosciences | 1.40B |
| AbCellera Biologics | 1.39B |
| Corvus Pharmaceuticals | 1.35B |
| GH Research | 1.35B |
| Savara | 1.34B |
| ArriVent BioPharma | 1.34B |